68Ga-DOTATOC, a somatostatin receptor–targeted ligand, has been used clinically in
Europe over the past decade for imaging neuroendocrine tumors (NETs). It appears to be …

Purpose The aim of this study was to assess the diagnostic performance of simultaneous
whole-body 68 Ga-DOTANOC PET/MRI compared with 68 Ga-DOTANOC PET/CT for …

Several authors reported the superiority of 68Ga-DOTANOC PET/CT to conventional
imaging (CI) for the assessment of neuroendocrine tumors (NET). However, the detection of …

Neuroendocrine tumors (NETs) are uncommon tumors with increasing incidence and
prevalence. Current reports suggest that 68Ga-DOTATATE PET/CT imaging improves …

Purpose Upon diagnosis, distant metastases are encountered in 21–50% of neuroendocrine
tumours (NETs). However, few systemic treatment options are available for the well …

Background Somatostatin analog functional imaging with gallium‐68 (Ga‐68) dotatate
positron emission tomography/computed tomography (PET/CT) has demonstrated …

Purpose: In patients with a neuroendocrine tumour (NET), the extent of disease strongly
influences the outcome and multidisciplinary therapeutic management. Thus, systematic …

Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

Our purpose was to evaluate the safety and efficacy of 68Ga-DOTATATE PET/CT compared
with 111In-pentetreotide imaging for diagnosis, staging, and restaging of pulmonary and …

68Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …